Skip to content

The Study of Combinatory effect of Cydonia oblanga, Cinnamomum zeylanicom, Pistacia lentiscus and Honey in Eradication of Gastric Helicobacter pylori Infection

The Study of Combinatory effect of Cydonia oblanga, Cinnamomum zeylanicom, Pistacia lentiscus and Honey in Eradication of Gastric Helicobacter pylori Infection in patients with dyspepsia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200128046288N3
Enrollment
60
Registered
2020-07-24
Start date
2020-09-19
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori and dyspepsia. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere

Interventions

Intervention 1: Intervention group: In addition to receiving routine treatment, 30 ml of herbal syrup will be taken twice a day for 2 weeks. The herbal syrup includes fruit of Quince, cinnamon, mastic

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: People who have one or more symptoms of dyspepsia (based on the Reflux Disease Questionnaire (RDQ)) Patients over 18 years with H.pylori positive test The women in the study had a negative pregnancy test

Exclusion criteria

Exclusion criteria: Having a chronic illness that leads to long-term use of a variety of medications. (Cardiovascular diseases, liver failure, kidney failure) Previous history of gastrointestinal ulcers or gastrointestinal bleeding Gasteric cancer Allergy to plants especially fruits of Quince, Cinnamon and mastic

Design outcomes

Primary

MeasureTime frame
Burning sensation in the back of the chest. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Feeling of pain in the back of the chest. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Heartburn. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Feeling of upper abdominal pain. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Acid taste. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Feeling the material move towards the top of the stomach. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Beiching. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Contusion. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Cough. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Swallowing disorder. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Bitter taste sensation. Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.;Feeling of movement of material in the stomach upwards (throat or mouth). Timepoint: Before and 2 week after the intervention. Method of measurement: Reflux Disease Questionnaire.

Secondary

MeasureTime frame
The rate of drug side effects. Timepoint: During drug use. Method of measurement: Patient Report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshteh golfakhrabadi

Ahvaz University of Medical Sciences

golfakhrabadi@yahoo.com+98 61 3373 8378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026